Last10K.com

Strongbridge Biopharma Plc (SBBP) SEC Filing 8-K Material Event for the period ending Monday, May 11, 2020

SEC Filings

Strongbridge Biopharma Plc

CIK: 1634432 Ticker: SBBP

View differences made from one to another to evaluate Strongbridge Biopharma Plc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Strongbridge Biopharma Plc.

Continue

Assess how Strongbridge Biopharma Plc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Strongbridge Biopharma Plc's Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Material Contracts, Statements, Certifications & more

Strongbridge Biopharma Plc provided additional information to their SEC Filing as exhibits

Ticker: SBBP
CIK: 1634432
Form Type: 8-K Corporate News
Accession Number: 0001634432-20-000021
Submitted to the SEC: Mon May 11 2020 8:02:49 AM EST
Accepted by the SEC: Mon May 11 2020
Period: Monday, May 11, 2020
Industry: Pharmaceutical Preparations
Events:
  1. Financial Exhibit
  2. Regulated Disclosure

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/sbbp/0001634432-20-000021.htm